The current market “is like no other” in U.S. history and it’s fate—and that of the U.S. economy—may depend on what happens in the next 45 days. Here’s why.
Read MoreHealthcare stocks remain a prime area of focus for my analysis right now, and will continue to be as all of North America struggles to find a justifiable reason to get national economies restarted. I think that the basis for any kind of reopening of businesses has to come from evidence not merely that infections […]
Read MoreThe investing veteran says the market may be in for “a double bottom” as earnings look grim and economic data becomes bleaker.
Read MoreHistory says that another big drop is coming soon. Here’s what investors need to know now.
Read MorePlus, the S&P may have just entered a new bull market, Darden Restaurants shares are up after it said to-go orders are surging, and Carnival shares are up after the Saudi sovereign wealth fund takes a big stake in the cruise operator.
Read MoreThis stock was one of the only stocks to end the first quarter in the black, and it’s headed for more upside ahead.
Read MoreThere’s just one catalyst that could trigger a meaningful rally higher. Here’s what investors need to know.
Read MorePlus, President Trump abandoned his hope of re-opening the U.S. economy by Easter as cases surge to more than 143,000, Macy’s said it is furloughing the majority of its 130,000 employees, and Johnson & Johnson said it will begin human trails on its experimental COVID-19 vaccine by September.
Read MorePlus, the $2 trillion stimulus bill has hit a snag in the House, the U.S. now has the most cases of the coronavirus in the world, and Novartis’ CEO said it’s “too soon” to say if two anti-malaria drugs will be an effective vaccine against the deadly virus.
Read MoreThe market hasn’t bottomed yet, but these are the key conditions to watch for.
Read MoreThe firm says these 6 stocks are their “best ideas” now.
Read MorePlus, 1 month and 3 month Treasury yields slipped into negative territory this morning, Target withdrew its full-year forecast, and Nike shares are rising after the sneaker maker reported better-than-expected sales.
Read MorePlus, the market is higher on optimism that a third stimulus bill will be finalized today, Gilead Sciences’ experimental COVID-19 treatment, remdesivir, received Orphan Drug Designation from the FDA, and General Motors said it is conserving cash and drawing down $16 billion from credit lines.
Read MoreI had to chuckle this weekend a bit as I read some some market news reports. The market has dropped far enough that in the latter part of the week, I think investors were starting to look for reasons to start buying. Friday looked set to mark the first time in weeks the market managed […]
Read MorePlus, the Fed issued new initiatives in an effort to calm the market, the Senate is still negotiating a $2 trillion stimulus package, GE’s aviation unit is laying off 10% of its workforce, and CVS is hiring 50,000 workers.
Read More